Glucocorticoid receptor dynamics and gene regulation

Stress

Volumn 12, Issue 3, 2009, Pages 193-205

  Biddie, Simon C ^a,b   Hager, Gordon L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Chromatin; Dynamics; Gene expression; Glucocorticoid receptor

Indexed keywords

GLUCOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR; ADENOSINE TRIPHOSPHATE; CHAPERONE; DNA BINDING PROTEIN; MNBP 1 PROTEIN, HUMAN; MNBP-1 PROTEIN, HUMAN; PROTEASOME;

DNA SEQUENCE; GENE CONTROL; GENETIC TRANSCRIPTION; GENOME; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, GENETIC; MOLECULAR CHAPERONES; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, GLUCOCORTICOID;

EID: 67949091258     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890802506409     Document Type: Review

References (109)

1. Agresti A, Scaffidi P, Riva A, Caiolfa VR, Bianchi ME. 2005. GR and HMGB1 interact only within chromatin and influence each other?s residence time. Mol Cell 18:109-121
2. Almlof T, Gustafsson JA, Wright AP. 1997. Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 17:934-945
3. Archer TK, Cordingley MG, Wolford RG, Hager GL. 1991. Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 11:688-698
4. Archer TK, Lee H-L, Cordingley MG, Mymryk JS, Fragoso G, Berard DS, Hager GL. 1994. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Mol Endocrinol 8(5):568-576
5. Assenmacher I, Barbanel G, Gaillet S, Givalois L, Ixart G, Malaval F, Mekaouche M, Siaud P, Szafarczyk A. 1995. Central regulation of ACTH release in stress. Ann NY Acad Sci 771: 41-54
6. Atkinson HC, Wood SA, Kershaw YM, BateE, Lightman SL. 2006. Diurnal variation in the responsiveness of the hypothalamic-pituitary-adrenal axis of the male rat to noise stress. J Neuroendocrinol 18:526-533
7. Baker SP, Grant PA. 2005. The proteasome: Not just degrading anymore. Cell 123:361-363
8. Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92: 367-380
9. Becker PB, Renkawitz R, Schutz G. 1984. Tissue-specific DNaseI hypersensitive sites in the 50-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. EMBO J 3:2015-2020
10. Becker M, Baumann CT, John S, Walker D, Vigneron M, McNally JG, Hager GL. 2002. Dynamic behavior of transcription factors on a natural promoter in living cells. EMBO Rep 3:1188-1194
11. Belikov S, Astrand C, Holmqvist PH, Wrange O. 2004a. Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo. Mol Cell Biol 24:3036-3047
12. Belikov S, Holmqvist PH, Astrand C, Wrange O. 2004b. Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction. J Biol Chem 279: 49857-49867
13. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2006. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126: 789-799
14. Borrell J, Torrellas A, Guaza C, Borrell S. 1980. Sound stimulation and its effects on the pituitary-adrenocortical function and brain catecholamines in rats. Neuroendocrinology 31:53-59
15. Bosisio D, Marazzi I, Agresti A, Shimizu N, Bianchi ME, Natoli G. 2006. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kB-dependent gene activity. EMBO J 25:798-810
16. Burakov D, Crofts LA, Chang CP, Freedman LP. 2002. Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 277:14359-14362
17. Cabrera R, Korte SM, Lentjes EG, Romijn F, Schonbaum E, de Nicola A, de Kloet ER. 2000. The amount of free corticosterone is increased during lipopolysaccharide-induced fever. Life Sci 66:553-562
18. Cartwright IL, Elgin SC. 1989. Nonenzymatic cleavage of chromatin. Methods Enzymol 170:359-369
19. Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS Jr. 1991. Creation of "super" glucocorticoid receptors by point mutations in the steroid binding domain. J Biol Chem 266: 22075-22078
20. Collins GA, Tansey WP. 2006. The proteasome: A utility tool for transcription? Curr Opin Genet Dev 16:197-202
21. De Bosscher K, Vanden Berghe W, Haegeman G. 2006. Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25:6868-6886
22. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. 2007. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130:1083-1094
23. Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK. 2002. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22:4113-4123
24. Dimitrov S, Moss T. 2001. UV laser-induced protein-DNA cross-linking. Methods Mol Biol 148:395-402
25. Dorschner MO, Hawrylycz M, Humbert R, Wallace JC, Shafer A, Kawamoto J, Mack J, Hall R, Goldy J, Sabo PJ, Kohli A, Li Q, McArthur M, Stamatoyannopoulos JA. 2004. High-throughput localization of functional elements by quantitative chromatin profiling. Nat Methods 1:219-225
26. Dostert A, Heinzel T. 2004. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des 10:2807-2816
27. Dundr M, Hoffmann-Rohrer U, Hu Q, Grummt I, Rothblum LI, Phair RD, Misteli T. 2002. A kinetic framework for a mammalian RNA polymerase in vivo. Science 298:1623-1626
28. Elbi C, Walker DA, Lewis M, Romero G, Sullivan WP, Toft DO, Hager GL, DeFranco DB. 2004a. A novel in situ assay for the identification and characterization of soluble nuclear mobility factors. Science STKE 2004:PL10
29. Elbi C, Walker DA, Romero G, Sullivan WP, Toft DO, Hager GL, DeFranco DB. 2004b. Molecular chaperones function as steroid receptor nuclear mobility factors. Proc Natl Acad Sci USA 101: 2876-2881
30. Fletcher TM, Ryu B-W, Baumann CT, Warren BS, Fragoso G, John S, Hager GL. 2000. Structure and dynamic properties of the glucocorticoid receptor-induced chromatin transition at the MMTV promoter. Mol Cell Biol 20:6466-6475
31. Fletcher TM, Xiao N, Mautino G, Baumann CT, Wolford RG, Warren BS, Hager GL. 2002. ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Mol Cell Biol 22:3255-3263
32. Ford J, McEwan IJ, Wright AP, Gustafsson JA. 1997. Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro. Mol Endocrinol 11:1467-1475
33. Fragoso G, Pennie WD, John S, Hager GL. 1998. The position and length of the steroid-dependent hypersensitive region in the mouse mammary tumor virus long terminal repeat are invariant despite multiple nucleosome B frames. Mol Cell Biol 18: 3633-3644
34. Freeman BC, Felts SJ, Toft DO, Yamamoto KR. 2000. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev 14: 422-434
35. Freeman BC, Yamamoto KR. 2002. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296: 2232-2235
36. Fryer CJ, Archer TK. 1998. Chromatin remodeling by the glucocorticoid receptor requires the BRG1 complex. Nature 393:88-91
37. Gallagher TF, Yoshida K, Roffwarg HD, Fukushima DK, Weitzman ED, Hellman L. 1973. ACTH and cortisol secretory patterns in man. J Clin. Endocrinol Metab 36:1058-1068
38. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O?Shea JJ, Chrousos GP, Bornstein SR. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71
39. Gannon F. 2005. Cycles EMBO Rep 6:899
40. Georgel PT, Fletcher TM, Hager GL, Hansen JC. 2003. Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters. Genes Dev 17(13):1617-1629
41. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM. 1986. Functional domains of the human glucocorticoid receptor. Cell 46:645-652
42. Godowski PJ, Rusconi S, Miesfeld R, Yamamoto KR. 1987. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement [published erratum appears in Nature 1987 Mar 5-11;326(6108):105]. Nature 325:365-368
43. Grange T, Roux J, Rigaud G, Pictet R. 1989. Two remote glucocorticoid responsive units interact cooperatively to promote glucocorticoid induction of rat tyrosine aminotransferase gene expression. Nucleic Acids Res 17:8695-8709
44. Hager GL, Elbi C, Johnson TA, Voss TC, Nagaich AK, Schiltz RL, Qiu Y, John S. 2006. Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res 14:107-116
45. Hager GL, Nagaich AK. 2006. Transcription factor dynamics. Gene expression and regulation. In: Ma J, editor. Higher education press. New York, Beijing: Springer. p 493-502
46. Hebbar PB, Archer TK. 2007. Chromatin-dependent cooperativity between site-specific transcription factors in vivo. J Biol Chem 282:8284-8291
47. Hockensmith JW, Kubasek WL, Vorachek WR, Evertsz EM, von Hippel PH. 1991. Laser cross-linking of protein-nucleic acid complexes. Methods Enzymol 208:211-236
48. Hollenberg SM, Evans RM. 1988. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899-906
49. Htun H, Barsony J, Renyi I, Gould DJ, Hager GL. 1996. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc Natl Acad Sci USA 93:4845-4850
50. Huang AL, Ostrowski MC, Berard D, Hager GL. 1981. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell 27: 245-255
51. Ichinose H, Garnier JM, Chambon P, Losson R. 1997. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene 188:95-100
52. John S, Johnson TA, Sung MH, Biddie SC, Trump S, Koch-Paiz CA, Davis SR, Walker R, Meltzer P, Hager GL. 2008a. Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology (submitted)
53. John S, Sabo PJ, Johnson TA, Sung MH, Biddie SC, Lightman SL, Voss TC, Davis SR, Meltzer PS, Stamatoyannopoulos JA, Hager GL. 2008b. Interaction of the glucocorticoid receptor with the global chromatin landscape. Mol Cell 29:611-624
54. Kang KI, MengX, vin-LeclercJ,Bouhouche I, ChadliA,Cadepond F, Baulieu EE, Catelli MG. 1999. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorti-costeroid-dependent promoter. Proc Natl Acad Sci USA 96: 1439-1444
55. Karin M. 1998. New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable? Cell 93:487-490
56. KeetonE,Fletcher TM, Baumann CT, Hager GL, Smith CL. 2002. Glucocorticoid receptor domain requirements for chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter in different nucleoprotein contexts. J Biol Chem 277:28247-28255
57. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. 1993. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366:170-174
58. Kinyamu HK, Archer TK. 2007. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphoryl-ation to enhance glucocorticoid receptor-mediated transcription. Mol Cell Biol 27:4891-4904
59. Kitchener P, Di BF, Borrelli E, Piazza PV. 2004. Differences between brain structures in nuclear translocation and DNA binding of the glucocorticoid receptor during stress and the circadian cycle. Eur J Neurosci 19:1837-1846
60. Klokk TI, Kurys P, Elbi C, Nagaich AK, Hendarwanto A, Slagsvold T, Chang CY, Hager GL, Saatcioglu F. 2007. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol Cell Biol 27:1823-1843
61. Kramer P, Fragoso G, Pennie WD, Htun H, Hager GL, Sinden RR. 1999. Transcriptional state of the mouse mammary tumor virus promoter can effect topological domain size in vivo. J Biol Chem 274:28590-28597
62. Lipford JR, Deshaies RJ. 2003. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat Cell Biol 5:845-850
63. Liu J, DeFranco DB. 1999. Chromatin recycling of glucocorticoid receptors: Implications for multiple roles of heat shock protein 90. Mol Endocrinol 13:355-365
64. Luecke HF, Yamamoto KR. 2005. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev 19:1116-1127
65. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 A resolution [see comments]. Nature 389:251-260
66. McEwan IJ, Wright APH, Dahlman-Wright K, Carlstedt-Duke J, Gustafsson J-A°. 1993. Direct interaction of the t1 transactivation domain of the human glucocorticoid receptor with the basal transcriptional machinery. Mol Cell Biol 13:399-407
67. McNally JG, Mueller WG, Walker D, Wolford RG, Hager GL. 2000. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287:1262-1265
68. Meijsing SH, Elbi C, Luecke HF, Hager GL, Yamamoto KR. 2007. The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release. Mol Cell Biol 27: 2442-2451
69. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
70. Molinari E, Gilman M, Natesan S. 1999. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J 18:6439-6447
71. Muchardt C, Yaniv M. 1993. A human homologue of Saccharo-myces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 12:4279-4290
72. Nagaich AK, Hager GL. 2004. UV laser cross-linking: A real-time assay to study dynamic protein/DNA interactions during chromatin remodeling. Sci STKE 256:PL13
73. Nagaich AK, Walker DA, Wolford RG, Hager GL. 2004. Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14:163-174
74. Nissen RM, Yamamoto KR. 2000. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14:2314-2329
75. Ong MS, Richmond TJ, Davey CA. 2007. DNA stretching and extreme kinking in the nucleosome core. J Mol Biol 368: 1067-1074
76. Orphanides G, Reinberg D. 2000. RNA polymerase II elongation through chromatin. Nature 407:471-475
77. Pandit S, Geissler W, Harris G, Sitlani A. 2002. Allosteric effects of dexamethasone and RU486 on glucocorticoid receptor-DNA interactions. J Biol Chem 277:1538-1543
78. Payvar F, DeFranco DB, Firestone GL, Edgar B, Wrange O, Okret S, Gustafsson JA, Yamamoto KR. 1983. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35(2 Pt 1): 381-392
79. Perlmann T, Wrange O. 1988. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J 7: 3073-3079
80. Planey SL, Abrams MT, Robertson NM, Litwack G. 2003. Role of apical caspases and glucocorticoid-regulated genes in gluco-corticoid-induced apoptosis of pre-B leukemic cells. Cancer Res 63:172-178
81. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL. 2006. HDAC1 acetylation is linked to progressive modulation of steroid receptor induced gene transcription. Mol Cell 22: 669-679
82. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707
83. Richard-Foy H, Hager GL. 1987. Sequence specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J 6:2321-2328
84. Richard-Foy H, Sistare FD, Riegel AT, Simons SS Jr, Hager GL. 1987. Mechanism of dexamethasone 21-mesylate antigluco-corticoid action: II. Receptor-antiglucocorticoid complexes are unable to interact productively with MMTV LTR chromatin in vivo. Mol Endocrinol 1:659-665
85. Rigaud G, Roux J, Pictet R, Grange T. 1991. In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67:977-986
86. Roe SM, Prodromou C, O'Brien R, Ladbury JE, Piper PW, Pearl LH. 1999. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldana-mycin. J Med Chem 42:260-266
87. RogatskyI, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, Yamamoto KR. 2003. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA 100:13845-13850
88. Sabo PJ, Kuehn MS, Thurman R, Johnson BE, Johnson EM, Cao H, Yu M, Rosenzweig E, Goldy J, Haydock A, Weaver M, Shafer A, Lee K, Neri F, Humbert R, Singer MA, Richmond TA, Dorschner MO, McArthur M, Hawrylycz M, Green RD, Navas PA, Noble WS, Stamatoyannopoulos JA. 2006. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat Methods 3:511-518
89. Saccani S, Natoli G. 2002. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16:2219-2224
90. Schaffner W. 1988. Gene regulation. A hit-and-run mechanism for transcriptional activation? [news]. Nature 336:427-428
91. Scheidereit C, Geisse S, Westphal HM, Beato M. 1983. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature 304(5928):749-752
92. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
93. Sharp ZD, Mancini MG, Hinojos CA, Dai F, Berno V, Szafran AT, Smith KP, Lele TT, Ingber DE, Mancini MA. 2006. Estrogen-receptor-alpha exchange and chromatin dynamics are ligand-and domain-dependent. J Cell Sci 119:4101-4116
94. Smith CL, Hager GL. 1997. Transcriptional regulation of mammalian genes in vivo: A tale of two templates. J Biol Chem 272:27493-27496
95. Smith DF, Whitesell L, Nair SC, Chen S, Prapapanich V, Rimerman RA. 1995. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 15:6804-6812
96. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O?Malley BW. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
97. Stavreva DA, Muller WG, Hager GL, Smith CL, McNally JG. 2004. Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol 24:2682-2697
98. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. 1989. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 257:E6-14
99. Voss TC, John S, Hager GL. 2006. Single cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription. Mol Endocrinol 20:2641-2655
100. Walker D, Htun H, Hager GL. 1999. Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods (Companion to Methods in Enzymology) 19:386-393
101. Wallberg AE, Neely KE, Hassan AH, Gustafsson J-A, Workman JL, Wright APH. 2000. Recruitment of the SWI-SNF chromatin remodeling complex as a mechanism of gene activation by the glucocorticoid receptor tau1 activation domain. Mol Cell Biol 20:2004-2013
102. Wang Q, Carroll JS, Brown M. 2005. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631-642
103. Wang Z, Malone MH, Thomenius MJ, Zhong F, Xu F, Distelhorst CW. 2003. Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J Biol Chem 278:27053-27058
104. Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. 1971. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14-22
105. Windle RJ, Shanks N, Lightman SL, Ingram CD. 1997. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138: 2829-2834
106. Wolffe AP, Hayes JJ. 1999. Chromatin disruption and modification. Nucleic Acids Res 27:711-720
107. Wu C. 1980. The 5? ends of Drosophila heat shock genes in chromatin are hypersensitive to DNase I. Nature 286(5776): 854-860
108. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. 1992. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258:1598-1604
109. Zhu P, Zhou W, Wang J, Puc J, Ohgi KA, Erdjument-Bromage H, Tempst P, Glass CK, Rosenfeld MG. 2007. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol Cell 27:609-621